Interleukin-1 Receptor Antagonist [EPC]

9804 reported adverse events

Drugs of this class: ANAKINRA

These side effects are most commonly reported by patients taking drugs of the Interleukin-1 Receptor Antagonist [EPC] class:

# Side effect Count
0 DRUG INEFFECTIVE 2708
1 OFF LABEL USE 2562
2 RHEUMATOID ARTHRITIS 1136
3 JOINT SWELLING 991
4 PAIN 983
5 CONDITION AGGRAVATED 826
6 DRUG INTOLERANCE 826
7 ARTHRALGIA 764
8 NAUSEA 636
9 INJECTION SITE PAIN 630
See all common reactions for Interleukin-1 Receptor Antagonist [EPC]

Drugs of the Interleukin-1 Receptor Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HUMAN ANTICHIMERIC ANTIBODY POSITIVE 265 0.9170
1 INFILTRATION ANAESTHESIA 21 0.7241
2 HUMAN ANTI-HUMAN ANTIBODY TEST 14 0.6364
3 ACTINOMYCOTIC SEPSIS 7 0.5385
4 BODY HEIGHT BELOW NORMAL 277 0.4663
5 CHRONIC INFANTILE NEUROLOGICAL CUTANEOUS AND ARTICULAR SYNDROME 8 0.4444
6 TUMOUR NECROSIS FACTOR RECEPTOR-ASSOCIATED PERIODIC SYNDROME 11 0.2750
7 ANKLE ARTHROPLASTY 44 0.2543
8 INTESTINAL SEPSIS 35 0.2381
9 SHORT STATURE 13 0.2321
See all enriched reactions for Interleukin-1 Receptor Antagonist [EPC]